Covid-19 Vaccine Market – By Type (Whole-Pathogen Vaccines, Subunit Vaccines, and Nucleic Acid Vaccines), By Application (Immunization and Others), By Route Of Administration (Oral and Intravenous), By End User (Hospitals, Home Care, Clinics, and Others), By Distribution Channel (Cold Storage Supply Chain and Others), By Region – Global Opportunity Analysis and Industry Forecast, 2019-2030

Covid-19 Vaccine Market will have the highest revenue generation in comparison to other vaccines and is projected to earn a revenue of more than USD XXX during 2020-2030. The projected revenue is expected to grow by an estimated CAGR of XXX during the forecasted period.Vaccines are the medically engineered products that are produced under controlled environment within the laboratories which have the ability to produces antigens in the bodies of infected patients. These antigens further boost the immunity within the host cell body to further create a fighting mechanism in the human body to fight against any infectious diseases that are caused due to harmful virus, bacteria and pathogens. The Covid-19 vaccine is yet to be introduced in the global market and is under trial by major pharmaceutical giants of different countries. The 5 big companies like GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Sanofi, Serum Institute of India, and Merck KgaA holds about 83% of covid-19 vaccine market share and have generated a revenue of more than USD 29 billion out of total revenue of USD 35 billion for the year 2018.

Market Segmentation:

The global Covid-19 vaccine market is segmented by type into whole-pathogen vaccines, subunit vaccines, and nucleic acid vaccines. Whole-pathogen vaccines are further divided into inactivated vaccines, live-attenuated vaccines, and chimeric vaccine. Subunit vaccines are further divided into polysaccharide vaccine, conjugate vaccine, toxoid vaccines, and recombinant protein vaccine. Nucleic acid vaccines are further divided into DNA plasmid vaccines, mRNA vaccines, and recombinant vector vaccines. By application, the global Covid-19 vaccine market is classified into immunization and others. By route of administration global Covid-19 vaccine market is categorized into oral and intravenous. By end-user global Covid-19 vaccine market is segregated into hospitals, home care, clinics, and others. By distribution channel, the global Covid-19 vaccine market is segmented into the cold storage supply chain and others. By region, the global Covid-19 vaccine market is categorized into North America, Asia- Pacific, Europe and RoW.

Market Dynamics and Factors:

Due to the lack of Covid-19 vaccine, currently other alternative of medicines are in use by the agencies of different government. Among such are National Institutes of Health (NIH), who is closely monitoring over the use of drug Remdesivir, which seems to be more effective in controlling the growth of the virus. Remdesivir is not declared as medicine or vaccine by WHO for the cure of Covid-19 but has been approved for clinical trial during the critical situation of a pandemic. In India, the drug-like hydroxychloroquine has been in most use, this drug is known for treating infections that are caused by pathogens. Hydroxychloroquine drug has shown improvement in cases where patients are infected by pneumonia and have shown speedy recovery by improving the infected area of lungs. The sale of these drugs has increased and are expected to generate more than USD 4 billion by the end of 2020. The growth of Covid-19 has shown speedy approach due to the increase in the numbers of deaths, whereas, due to unavailability of technological advancement and critical nature of virus, it has made more complex for the vaccine manufacturer to prepare the vaccine in a much shorter duration.

Geographic Scenario

North America is the largest revenue generating region with largest covid-19 vaccine market share of more than 65% during 2018. Looking into the current scenario of Covid-19 pandemic situation, USA seems to be worst affected country and will be the largest consumer of vaccine by 2021. According to report shared by major companies there will be consumption of more than 5 billion units of vaccine worldwide and each unit is expected to cost INR. 1000 in Asian countries like India, and USD 1,000 – 2000 per unit worldwide.

Competitive Scenario:

The World Health Organization (WHO) has shared a data of 5 candidates for vaccines which are involved in clinical evaluation namely CanSino Biological Inc. & Beijing Institute of Biotechnology, Inovio Pharmaceuticals, Beijing Institute of Biological Products & Wuhan Institute of Biological Products, Sinovac, and Moderna & NIAID. These collaborated companies are in different stages of clinical trials and are major players in the process of manufacturing potential vaccine. Also, there are other 71 candidates for vaccines who are in stage of pre-clinical evaluation.

Covid-19 Vaccine Market Report Scope